236 related articles for article (PubMed ID: 15037715)
1. POMT1 mutation results in defective glycosylation and loss of laminin-binding activity in alpha-DG.
Kim DS; Hayashi YK; Matsumoto H; Ogawa M; Noguchi S; Murakami N; Sakuta R; Mochizuki M; Michele DE; Campbell KP; Nonaka I; Nishino I
Neurology; 2004 Mar; 62(6):1009-11. PubMed ID: 15037715
[TBL] [Abstract][Full Text] [Related]
2. Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome.
Beltrán-Valero de Bernabé D; Currier S; Steinbrecher A; Celli J; van Beusekom E; van der Zwaag B; Kayserili H; Merlini L; Chitayat D; Dobyns WB; Cormand B; Lehesjoki AE; Cruces J; Voit T; Walsh CA; van Bokhoven H; Brunner HG
Am J Hum Genet; 2002 Nov; 71(5):1033-43. PubMed ID: 12369018
[TBL] [Abstract][Full Text] [Related]
3. The expanding phenotype of POMT1 mutations: from Walker-Warburg syndrome to congenital muscular dystrophy, microcephaly, and mental retardation.
van Reeuwijk J; Maugenre S; van den Elzen C; Verrips A; Bertini E; Muntoni F; Merlini L; Scheffer H; Brunner HG; Guicheney P; van Bokhoven H
Hum Mutat; 2006 May; 27(5):453-9. PubMed ID: 16575835
[TBL] [Abstract][Full Text] [Related]
4. Mutations of the POMT1 gene found in patients with Walker-Warburg syndrome lead to a defect of protein O-mannosylation.
Akasaka-Manya K; Manya H; Endo T
Biochem Biophys Res Commun; 2004 Dec; 325(1):75-9. PubMed ID: 15522202
[TBL] [Abstract][Full Text] [Related]
5. POMT2 mutations cause alpha-dystroglycan hypoglycosylation and Walker-Warburg syndrome.
van Reeuwijk J; Janssen M; van den Elzen C; Beltran-Valero de Bernabé D; Sabatelli P; Merlini L; Boon M; Scheffer H; Brockington M; Muntoni F; Huynen MA; Verrips A; Walsh CA; Barth PG; Brunner HG; van Bokhoven H
J Med Genet; 2005 Dec; 42(12):907-12. PubMed ID: 15894594
[TBL] [Abstract][Full Text] [Related]
6. Extracellular matrix and nuclear abnormalities in skeletal muscle of a patient with Walker-Warburg syndrome caused by POMT1 mutation.
Sabatelli P; Columbaro M; Mura I; Capanni C; Lattanzi G; Maraldi NM; Beltràn-Valero de Barnabè D; van Bokoven H; Squarzoni S; Merlini L
Biochim Biophys Acta; 2003 May; 1638(1):57-62. PubMed ID: 12757935
[TBL] [Abstract][Full Text] [Related]
7. Walker-Warburg syndrome.
Vajsar J; Schachter H
Orphanet J Rare Dis; 2006 Aug; 1():29. PubMed ID: 16887026
[TBL] [Abstract][Full Text] [Related]
8. Profound skeletal muscle depletion of alpha-dystroglycan in Walker-Warburg syndrome.
Jiménez-Mallebrera C; Torelli S; Brown SC; Feng L; Brockington M; Sewry CA; Beltrán-Valero De Bernabé D; Muntoni F
Eur J Paediatr Neurol; 2003; 7(3):129-37. PubMed ID: 12788039
[TBL] [Abstract][Full Text] [Related]
9. Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan.
Longman C; Brockington M; Torelli S; Jimenez-Mallebrera C; Kennedy C; Khalil N; Feng L; Saran RK; Voit T; Merlini L; Sewry CA; Brown SC; Muntoni F
Hum Mol Genet; 2003 Nov; 12(21):2853-61. PubMed ID: 12966029
[TBL] [Abstract][Full Text] [Related]
10. Targeted disruption of the Walker-Warburg syndrome gene Pomt1 in mouse results in embryonic lethality.
Willer T; Prados B; Falcón-Pérez JM; Renner-Müller I; Przemeck GK; Lommel M; Coloma A; Valero MC; de Angelis MH; Tanner W; Wolf E; Strahl S; Cruces J
Proc Natl Acad Sci U S A; 2004 Sep; 101(39):14126-31. PubMed ID: 15383666
[TBL] [Abstract][Full Text] [Related]
11. Brain involvement in muscular dystrophies with defective dystroglycan glycosylation.
Clement E; Mercuri E; Godfrey C; Smith J; Robb S; Kinali M; Straub V; Bushby K; Manzur A; Talim B; Cowan F; Quinlivan R; Klein A; Longman C; McWilliam R; Topaloglu H; Mein R; Abbs S; North K; Barkovich AJ; Rutherford M; Muntoni F
Ann Neurol; 2008 Nov; 64(5):573-82. PubMed ID: 19067344
[TBL] [Abstract][Full Text] [Related]
12. Glyc-O-genetics of Walker-Warburg syndrome.
van Reeuwijk J; Brunner HG; van Bokhoven H
Clin Genet; 2005 Apr; 67(4):281-9. PubMed ID: 15733261
[TBL] [Abstract][Full Text] [Related]
13. Congenital muscular dystrophy with glycosylation defects of alpha-dystroglycan in Japan.
Matsumoto H; Hayashi YK; Kim DS; Ogawa M; Murakami T; Noguchi S; Nonaka I; Nakazawa T; Matsuo T; Futagami S; Campbell KP; Nishino I
Neuromuscul Disord; 2005 May; 15(5):342-8. PubMed ID: 15833426
[TBL] [Abstract][Full Text] [Related]
14. Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan.
Godfrey C; Clement E; Mein R; Brockington M; Smith J; Talim B; Straub V; Robb S; Quinlivan R; Feng L; Jimenez-Mallebrera C; Mercuri E; Manzur AY; Kinali M; Torelli S; Brown SC; Sewry CA; Bushby K; Topaloglu H; North K; Abbs S; Muntoni F
Brain; 2007 Oct; 130(Pt 10):2725-35. PubMed ID: 17878207
[TBL] [Abstract][Full Text] [Related]
15. Mutations in POMT1 are found in a minority of patients with Walker-Warburg syndrome.
Currier SC; Lee CK; Chang BS; Bodell AL; Pai GS; Job L; Lagae LG; Al-Gazali LI; Eyaid WM; Enns G; Dobyns WB; Walsh CA
Am J Med Genet A; 2005 Feb; 133A(1):53-7. PubMed ID: 15637732
[TBL] [Abstract][Full Text] [Related]
16. Correlation of enzyme activity and clinical phenotype in POMT1-associated dystroglycanopathies.
Lommel M; Cirak S; Willer T; Hermann R; Uyanik G; van Bokhoven H; Körner C; Voit T; Barić I; Hehr U; Strahl S
Neurology; 2010 Jan; 74(2):157-64. PubMed ID: 20065251
[TBL] [Abstract][Full Text] [Related]
17. [Defective O-mannosyl glycosylation causes congenital muscular dystrophies].
Manya H; Endo T
Tanpakushitsu Kakusan Koso; 2004 Nov; 49(15 Suppl):2451-6. PubMed ID: 15553000
[No Abstract] [Full Text] [Related]
18. Milder phenotype of congenital muscular dystrophy in a novel POMT1 mutation.
Al-Zaidy SA; Baskin B; Hawkins C; Yoon G; Ray PN; Vajsar J
Muscle Nerve; 2012 May; 45(5):752-5. PubMed ID: 22499106
[TBL] [Abstract][Full Text] [Related]
19. Analysis of phenotype, enzyme activity and genotype of Chinese patients with POMT1 mutation.
Yang H; Manya H; Kobayashi K; Jiao H; Fu X; Xiao J; Li X; Wang J; Jiang Y; Toda T; Endo T; Wu X; Xiong H
J Hum Genet; 2016 Aug; 61(8):753-9. PubMed ID: 27193224
[TBL] [Abstract][Full Text] [Related]
20. Congenital muscular dystrophy with muscle inflammation alpha dystroglycan glycosylation defect and no mutation in FKRP gene.
Lamperti C; Cagliani R; Ciscato P; Moroni I; Viri M; Romeo A; Fagiolari G; Prelle A; Comi GP; Bresolin N; Moggio M
J Neurol Sci; 2006 Apr; 243(1-2):47-51. PubMed ID: 16386759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
